Updated 18:03 GMT, 5 Nov 2026 SPX 7,427.81 -3.39% NDX 26,945.57 -5.25% VIX 23.84 +43.53% GOLD 4,132.30 +1.46% CL 90.22 +2.38% BTC 75,632.84 -5.94%
NAS100 26,946 −5.25% S&P 7,428 −3.39% GOLD $4,132 +1.46% BTC $75,633 −5.94% VIX 23.84 +43.53% latest tape · as of 18:03 UTC
The Screen · Basic Materials · Building Materials

Buzzi S.p.A.

BZZUY · PNK · USD · Market cap $8.4B · 10,275 employees

Buzzi S.p.A., together with its subsidiaries, manufactures, distributes, and sells cement, ready-mix concrete, and natural aggregates.

PASS · Titan Ethical · score 70.0
24.20 USD

Price as of 4 Nov 2026Daily close, not a live quote

Screened 2026-11-04 · the tape above runs as of 18:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price24.20 USD at the 4 Nov 2026 close
  • Fair value23.64. Our model only; only one analyst covers it, too few to cross-check it.
  • Our value readFair vs our fair value, as of 4 Nov 2026
  • Our regime readMarkup, as of 4 Nov 2026
  • Ethical screenPasses, score 70.0 out of 100
  • Last reviewed4 Nov 2026 (1 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $23.64 to $27.19, base estimate $23.64 (screen dated 2026-11-04).

Current read
Markup ?
Fair · screened 2026-11-04
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price24.20 USD
Fair value23.64Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-10-21Read Markup22.00+10.0% to today ✓Distribution gives way to Markup after an 18% slide in 16 weeks
2026-07-02Read Distribution26.90-10.0% to today ✓First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Buzzi S.p.A. holds its Markup at $24.20. Consolidating, no directional conviction, held for 3 days.

As held on the ledger · 2026-11-04
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 3 days
Price at the screen$24.20
Valuation8.63 trailing · 8.74 forward price to earnings
Values screenPASS · score 70.0
Beta1.00
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 4.55% Below 33% Interest-bearing debt is just 4.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 14.47% Below 33% Cash held in interest-bearing accounts and securities is 14.5% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 1.99% Below 5% Only 2.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Buzzi S.p.A. clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 5%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.

Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when BZZUY's ethical verdict changes

Today BZZUY passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; only one analyst covers it, too few to cross-check it.

Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades above our $23.64 fair value estimate, moderate competitive moat, 0.10% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

23.64Conservative23.64Base case27.19Growth case 24.20Price

Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 2.4% above the base estimate.

Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $23.64, with a range of $23.64 to $27.19, dated to the 2026-11-04 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Cement maker looks cheap but cycles often trap

Picture a builder in Milan or Texas finishing a project and Buzzi supplies the cement that holds it together. The stock trades at 8.8 times forward earnings with a 20 percent profit margin and 13 percent return on equity, numbers that look attractive next to a modest 3 percent revenue growth rate and a moderate moat in a fragmented market.

Yet this is exactly the setup that catches investors in cyclical value traps. Peak earnings from the current construction cycle can make any multiple look low, while the thin 2 percent margin of safety offers little cushion when volumes or prices turn.

Currency swings, energy costs and regional construction slowdowns remain real threats even though the ethical screen clears and one analyst sees upside to 32 dollars. The low multiple is a warning, not a bargain.

Analysis, not advice.

The fundamentals · plain-English read
Forward P/E8.7xexpensive even after accounting for its growth
Trailing P/E8.6xvery cheap relative to earnings
EPS, trailing2.78
EPS, forward2.74
Revenue growth+0.1%slow but positive growth
Profit margin19.0%healthy profit margins
Return on equity12.3%a solid return on shareholder capital
FCF yield0.24%
Dividend yield151.00%
Debt to equity0.07minimal debt: a conservative balance sheet
Current ratio4.39comfortably covers its short-term bills
Beta1.00steadier than the market
52-week range20.15 - 32.22
MoatMODERATE
Market cap$8.4B
Employees10,275

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to Italy and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

BZZUY trades on PNK (the company is based in Italy). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-02 Markup $22.69 +3.1% Entry 9

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $31.

2026-10-21 Markup · changed $22.00 +2.3% Entry 8

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $31. Since the last review it its composite score eased.

2026-10-14 Distribution $21.51 -0.6% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $31.

2026-10-02 Distribution $21.63 -14.2% Entry 6

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it strong buy, with a mean price target of $31.

2026-08-24 Distribution $25.20 +2.6% Entry 5

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $35.

2026-07-24 Distribution $24.55 -8.7% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $35.

2026-07-18 Distribution $26.90 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (1 analysts) rates it none, with a mean price target of $35.

2026-07-03 Distribution $26.90 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Distribution $26.90 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on BZZUY

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in BZZUY's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $28.68 -11.4% $0.41 $900 -10.0%
2 months $27.02 -6.0% $0.41 $955 -4.5%
3 months $25.03 +1.5% $0.41 $1,031 +3.1%
6 months $29.57 -14.1% $0.41 $873 -12.7%
1 year $26.06 -2.6% $0.41 $990 -1.0%
2 years $20.18 +25.9% $0.81 $1,298 +29.8%
3 years $11.37 +123.5% $1.13 $2,334 +133.4%
5 years $13.05 +94.7% $1.59 $2,068 +106.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever BZZUY does next, these words stay.

Buzzi S.p.A. · BZZUY · Markup · $24.20
Recorded 2026-11-04 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.